OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020

    NEXT STORY
    Allogene Therapeutics and MD Anderson Announce Strategic Collaboration to Accelerate Advancement of Allogeneic CAR T Therapy (AlloCAR T™)
    PREV STORY
    OncXerna Therapeutics to Participate at the Jefferies Virtual London Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AzurRx BioPharma Announces Agreement in Principle with TransChem for MTAN Inhibition Technology

    BROOKLYN, N.Y., Dec. 06, 2016 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc. (NASDAQ:AZRX) (“AzurRx” or ...

    author_avatar
    NASDAQ Market News

    Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine

    author_avatar
    NASDAQ Market News

    Invuity Announces Pricing of Public Offering of Common Stock

    SAN FRANCISCO, July 28, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the ...

    author_avatar
    NASDAQ Market News